Discrepant views of oncologists and cancer patients on complementary/ alternative medicine

Supportive Care in Cancer

Volumn 12, Issue 11, 2004, Pages 797-804

  Richardson, Mary Ann ^a   Mâsse, Louise C ^b   Nanny, Kelly ^c   Sanders, Christina ^c  

^a Natl Found for Alternative Med   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alternative; Attitudes; Communication; Complementary medicine

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; BIOSAFETY; CANCER CENTER; CANCER PATIENT; CANCER THERAPY; CHI SQUARE TEST; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; HUMAN; INTERPERSONAL COMMUNICATION; LIFE EXPECTANCY; MEDICAL SPECIALIST; ONCOLOGY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; TOXICITY;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

EID: 11244317426     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0677-3     Document Type: Article

References (37)

1. Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: A qualitative study in women with breast cancer. J Fam Pract 48(6):453-458
2. Ashikaga T, Bosompra K, O'Brien P, Nelson L (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10(7):542-548
3. Boon H, Stewart M, Kennard M, Gray R, Sawka C, Brown J, McWilliam C, Gavin A, Baron R, Aaron D, et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515-2521
4. Bruera E, Willey J, Palmer J, Rosales M (2002) Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer 94:2976-3080
5. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. JAMA 340(22):1733-1739
6. Charles C, Whelan T, Gafni A, Willan A, Farrell S (2003) Shared treatment decision making: waht does it mean to physicians? J Clin Oncol 21(5):932-936
7. Conklin K (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37(1):1-18
8. Corbin Winslow L, Shapiro H (2002) Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 162(10):1176-1181
9. Eisenberg DM (1997) Advising patients who seek alternative medical therapies. Ann Inter Med 127(1):61-69
10. Gotay C, Hara W, Issell B, Maskarinec G (1999) Use of complemetnary and alternative medicine in Hawaii cancer patients. Hawaii Med J 58(4):94-95
11. Hyodo I, Eguchi K, Nishina T, Endo H, Tanimizu M, Mikami I, Takashima S, Imanishi J (2003) Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer 97(11):2861-2868
12. Kappauf H, Leykauf-Ammon D, Bruntsch U, Horneber M, Kaiser G, Buschel G, Gallmeir W (2000) Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and heaemetology. Support Care Cancer 8(4):314-322
13. Keating N, Guadagnoli E, Landrum M, Borbas C, Weeks J (2002) Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol 20(6):1473-1479
14. Kelly K, Jacobson J, Kennedy D, Braudt S, Mallick M, Weiner M (2000) Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 22(5):412-426
15. Lamson D, Brignall M (1999) Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 4(5):304-329
16. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92(1):42-47
17. Lerner IJ, Kennedy BJ (1992) The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 42(3):181-191
18. Mathijssen R, Verweij J, de Bruijn P, Loos W, Sparreboom A (2002) Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94(16):1247-1249
19. McCurdy E, Spangler J, Wofford M, Chauvenet A, McLean T (2001) Complementary and alternative therapy use in pediatric oncology patients. J Ped Hem Onc A27
20. Morris K, Johnson N, Horner L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179:407-411
21. Moschen R, Kemmler G, Schweigkofler H, Holzner B, Dunser M, Richter R, Fleischhacker, Sperner-Uterweger B (2001) Use of alternative/complementary therapy in breast cancer patients-a psychological perspective. Support Care Cancer 9:267-274
22. Moyad M (2001) The prevalence and effectiveness of complementary and alternative medicine: what has been learned and what it may be telling us about our patients, ourselves, and conventional medical treatment. Semin Urol Oncol 19(4):257-269
23. National Center for Complementary and Alternative Medicine. Expanding horizons of healthcare: The five-year NCCAM strategic plan 2001-2005. http://nccam.nih.gov/about/plans/five-year/index.htm. Cited 20 July 2004
24. Powell C, Dibble S, Dall'era J, Cohen I (2002) Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 12:214-217
25. Rees R, Feigel I, Vickers A, Zollman C, McGurk R, Smith C (2000) Prevalence of complementary therapy use by women with breast cancer: a population-based survey. Eur J Cancer 36:1359-1364
26. Richardson M, Straus S (2002) Complementary and alternative medicine: Opportunities and challenges for cancer management and research. Semin Oncol 29 (6):531-535
27. Richardson MA, Ramirez T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505-2514
28. Sandler R, Halabi S, Kaplan E, Baron J, Paskett E, Petrelli N (2001) Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial. Cancer 91:1040-1045
29. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. Cancer 89(4):873-880
30. Sparber A (2001) Clinical center sets new policy on use of herbal and other alternative supplements by CC patients. NIH Catalyst 9(6):8-9
31. Sparber A, Bauer L, Curt G, Eisenerg D, Levin T, Parks S, Steinberg S, Wooton J (2002) Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 27(4):623-630
32. Tasaki K, Maskarinec G, Shumay D, Tatsumura Y, Kakai H (2002) Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncol 11():212-220
33. Verhoef MJ, Hagen N, Pelletier G, Forsyth P (1999) Alternative therapy use in neurologic diseases. Neurology 52:617-622
34. Von Gruenigen V, White L, Kirven M, Showalter A, Hopkins M (2000) A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 11:205-209
35. Weiger W, Smith M, Boon H, Richardson M, Kaptchuk T, Eisenberg D (2002) Adivising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137:889-903
36. Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Reviews 23:209-240
37. Zeisel S, Salganik R (1999) Special commentary: antioxidants and nutrition support. Curr Opin Clin Nutr Metab Care 2(1):1-3